Advertisement

Topics

AstraZeneca's #lungcancer drug #Imfinzi gets orphan drug designation from #FDA http://bit.ly/2LLo4X3  #cancer #oncologypic.twitter.com/tFvDnH4IBF

14:45 EDT 12 Jul 2019 | Pharmafile

AstraZeneca's drug gets orphan drug designation from http://bit.ly/2LLo4X3 

Original Article: AstraZeneca's #lungcancer drug #Imfinzi gets orphan drug designation from #FDA http://bit.ly/2LLo4X3  #cancer #oncologypic.twitter.com/tFvDnH4IBF

NEXT ARTICLE

More From BioPortfolio on "AstraZeneca's #lungcancer drug #Imfinzi gets orphan drug designation from #FDA http://bit.ly/2LLo4X3  #cancer #oncologypic.twitter.com/tFvDnH4IBF"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...